BB
Bond Biosciences, Inc.
SEC filingOther Health Care · Parkville, MO
Amount raised$5.9Msold at filing
Total offering$15M$9.1M still open
Investors in the raise83count reported to the SEC
FiledJun 4, 2026first sale Apr 1, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Cory BerklandExecutive Officer, Director
Timothy OplerDirector
Michael BeckloffDirector
Michael A. RileyExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.